|Bid||0.00 x 1800|
|Ask||0.00 x 800|
|Day's Range||5.34 - 5.60|
|52 Week Range||2.52 - 8.27|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 04, 2020|
|Forward Dividend & Yield||0.80 (14.55%)|
|Ex-Dividend Date||Nov 16, 2020|
|1y Target Est||N/A|
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84).
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Wednesday, December 2, 2020, at 8:00 a.m. ET.
Generation Investment Management releases quarterly portfolio